Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity

Ke Xu,Na Yin,Min Peng,Amy Shyu,Peng Li,Xian Zhang,Zhaoquan Wang,Chun Chou,Efstathios G. Stamatiades,Mytrang H. Do,Kristelle J. Capistrano,Andrew G. Levine,Alexander Y. Rudensky,Ming O. Li
DOI: https://doi.org/10.1126/science.abb2683
IF: 56.9
2021-01-22
Science
Abstract:A metabolic circuit in T cell immunity Naïve T cells are metabolically reprogrammed when they differentiate into T effector (T eff ) cells, transitioning from a reliance on mitochondrial oxidative phosphorylation to aerobic glycolysis. Xu et al. found that lactate dehydrogenase A (LDHA), a glycolytic enzyme that converts pyruvate to lactate, is a key player in this process. T eff cells that differentiate in mice infected with the bacterium Listeria monocytogenes turned on LDHA through phosphoinositide 3-kinase (PI3K) signaling. By promoting adenosine triphosphate (ATP) production, LDHA in turn facilitated PI3K-dependent inactivation of the transcription factor Foxo1 needed for effective T eff cell responses. Thus, glycolytic ATP acts like a rheostat that both gauges and regulates PI3K-dependent signaling. This type of positive feedback circuit may also provide a mechanistic explanation for the Warburg effect observed in cancer cells. Science , this issue p. 405
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: the role of lactate dehydrogenase A (LDHA) in CD8+ effector T cells through the phosphatidylinositol 3 - kinase (PI3K) signaling pathway and its impact on T - cell immune function. Specifically, the researchers explored how LDHA enhances the T - cell immune response against microbial infections by promoting PI3K signal transduction, and how LDHA deficiency affects this process. ### Research Background - **T - cell metabolic reprogramming**: When naive T cells differentiate into effector T cells (Teff), it is accompanied by metabolic reprogramming to support their proliferation and effector functions. - **Function of LDHA**: LDHA is a glycolytic enzyme that can convert pyruvate into lactate. It is known to be up - regulated in Teff cells and promotes cytokine expression in Teff cells. - **PI3K signaling pathway**: The PI3K signaling pathway plays a crucial role in T - cell activation and differentiation, regulating T - cell function by phosphorylating Akt and the transcription factor Foxo1. ### Research Objectives - **Verify the role of LDHA in T - cell immunity**: The researchers hope to experimentally verify whether LDHA plays an important role in T - cell immunity through the PI3K signaling pathway. - **Explore the impact of LDHA deficiency**: Study the specific effects of LDHA deficiency on T - cell proliferation, differentiation, and immune function, especially on the PI3K - Akt - Foxo1 signaling pathway. ### Main Findings - **Expression of LDHA in Teff cells**: The researchers found that LDHA is up - regulated in CD8+ effector T cells through the PI3K signaling pathway. - **Impact of LDHA deficiency**: - **Impaired signaling pathway**: LDHA deficiency leads to impaired phosphorylation of PI3K - dependent Akt and Foxo1. - **Cellular function defects**: T cells with LDHA deficiency show decreased proliferation ability, reduced ATP production, and impaired redox control. - **Weakened immune function**: In mouse infection experiments, mice with LDHA deficiency cannot effectively clear pathogens, indicating that their anti - microbial immune function is impaired. - **Mechanism exploration**: The researchers further found that LDHA maintains the activity of the PI3K - Akt - Foxo1 signaling pathway by promoting ATP produced by glycolysis, thereby regulating T - cell immune function. ### Conclusions - **Importance of LDHA in T - cell immunity**: LDHA plays a key role in T - cell immunity by promoting ATP produced by glycolysis and maintaining the activity of the PI3K - Akt - Foxo1 signaling pathway. - **Potential mechanism**: This mechanism may explain the Warburg effect observed in cancer cells, that is, cancer cells tend to use glycolysis rather than mitochondrial oxidative phosphorylation to generate energy. Through these findings, the researchers provide a new perspective for understanding the relationship between T - cell metabolism and immune function, and provide potential targets for the development of immunotherapies for infectious diseases and cancer.